Tremblant Capital Group Teva Pharmaceutical Industries LTD Transaction History
Tremblant Capital Group
- $836 Million
- Q1 2025
A detailed history of Tremblant Capital Group transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tremblant Capital Group holds 42,000 shares of TEVA stock, worth $735,000. This represents 0.05% of its overall portfolio holdings.
Number of Shares
42,000Holding current value
$735,000% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TEVA
# of Institutions
660Shares Held
626MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$752 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$683 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$661 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$511 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$487 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...